SCHEMBL7984753

SCHEMBL7984753

CCc1nc2ncn(Cc3cccc(Cl)c3)c2c(=O)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.51
GLA P06280 1/20 0.51
HTT P42858 1/20 0.51
UBE2N P61088 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
HPGD P15428 1/20 0.48
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 1/20 0.47
YTHDC1 Q96MU7 2/20 0.43
BRD4 O60885 2/20 0.42
BRD2 P25440 1/20 0.42
BRD3 Q15059 1/20 0.42
BRDT Q58F21 1/20 0.42
ACP1 P24666 1/20 0.42
HCAR2 Q8TDS4 1/20 0.41
MAPK1 P28482 1/20 0.41
GAA P10253 1/20 0.41
HTR6 P50406 1/20 0.41
P2RX7 Q99572 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991723 0.91 SMN1; SMN2 (0.49) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7975251 0.88 SMN1; SMN2 (0.60) SMN1; SMN2L3MBTL1HPGDALDH1A1KMT2A
SCHEMBL7987671 0.88 SMN1; SMN2 (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7974255 0.88 HPGD (0.47) SMN1; SMN2HTTHPGDALDH1A1KMT2A
Hydrochloric Acid SCHEMBL7987800 0.87 HPGD (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988672 0.87 SMN1; SMN2 (0.47) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7984206 0.87 HPGD (0.46) SMN1; SMN2HPGDALDH1A1KMT2AHCAR2
SCHEMBL7984510 0.85 GAA (0.53) SMN1; SMN2HPGDALDH1A1KMT2AYTHDC1
SCHEMBL7984496 0.85 HPGD (0.45) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7985648 0.83 HPGD (0.47) SMN1; SMN2HPGDALDH1A1KMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed